...
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations
Shopping cart close
Scilex Holding Scilex Holding
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations

SEC FIlings

Home » Archive by Category "SEC FIlings" (Page 10)
15 Nov
SEC FIlings

 Initial statement of beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

15 Nov
SEC FIlings

Initial statement of changes in beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

15 Nov
SEC FIlings

Initial statement of beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

15 Nov
SEC FIlings

Initial statement of beneficial ownership of securities

  • December 14, 2022
  • Posted by Jitendra

Read more

14 Nov
SEC FIlings

Statement of acquisition of beneficial ownership by individuals – Amendment

  • November 17, 2022
  • Posted by Jitendra

Read more

10 Nov
SEC FIlings

Notification of removal from listing and/or registration

  • November 17, 2022
  • Posted by Jitendra

Read more

09 Nov
SEC FIlings

Current report

  • November 17, 2022
  • Posted by Jitendra

Read more

04 Nov
SEC FIlings

Quarterly report for quarter ending Sept 30, 2022

  • November 17, 2022
  • Posted by Jitendra

Read more

31 Oct
SEC FIlings

Prospectuses and communications, business combinations

  • November 17, 2022
  • Posted by Jitendra

Read more

31 Oct
SEC FIlings

Current report

  • November 17, 2022
  • Posted by Jitendra

Read more

«‹89101112›»
Close
Recent Posts
  • Nasdaq_Gloperba03
    Gloperba Launch – Nasdaq-2024
    July 10, 2024 No Comments
  • A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
    June 14, 2024 No Comments
  • Gout Awareness Day – May 22
    May 20, 2024 No Comments
  • Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
    March 14, 2024 No Comments
  • Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch
    March 14, 2024 No Comments

scilex-holding-logo-white

Terms of Use  Privacy Policy  Contact

  • Follow us on Facebook
  • Follow us on LinkedIn
  • Contact us by email

©2024 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

Scroll To Top Sidebar
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept More info